Treatment Outcomes from 68Ga-PSMA PET/CT-Informed Salvage Radiation Treatment in Men with Rising PSA After Radical Prostatectomy: Prognostic Value of a Negative PSMA PET.

@article{Emmett2017TreatmentOF,
  title={Treatment Outcomes from 68Ga-PSMA PET/CT-Informed Salvage Radiation Treatment in Men with Rising PSA After Radical Prostatectomy: Prognostic Value of a Negative PSMA PET.},
  author={Louise Emmett and Pim J van Leeuwen and Rohan Nandurkar and Matthijs Jv Scheltema and Thomas Cusick and George Hruby and Andrew Kneebone and Thomas N Eade and Gerald B Fogarty and Raj S Jagavkar and Quoc A Nguyen and Bao Quoc Ho and Anthony Michael Joshua and Phillip D Stricker},
  journal={Journal of nuclear medicine : official publication, Society of Nuclear Medicine},
  year={2017},
  volume={58 12},
  pages={
          1972-1976
        }
}
68Ga-PSMA (prostate-specific membrane antigen) PET/CT is increasingly used in men with prostate-specific antigen (PSA) failure after radical prostatectomy (RP) to triage those who will benefit from salvage radiation treatment (SRT). This study examines the value of PSMA-informed SRT in improving treatment outcomes in the context of biochemical failure after RP. Methods: We analyzed men with rising PSA after RP with PSA readings between 0.05 and 1.0 ng/mL, considered eligible for SRT at the time… CONTINUE READING
Related Discussions
This paper has been referenced on Twitter 35 times. VIEW TWEETS

Citations

Publications citing this paper.
Showing 1-8 of 8 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 21 references

The Impact of 68Ga-PSMA PET/CT on Management Intent in Prostate Cancer: Results of an Australian Prospective Multicenter Study.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine • 2018
View 1 Excerpt

Impact of 68Ga-PSMA-11 PET on Management in Patients with Biochemically Recurrent Prostate Cancer.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine • 2017
View 1 Excerpt

Prospective evaluation of 68galliumPSMA positron emission tomography/computerized tomography for preoperative lymph node staging in prostate cancer

PJ van Leeuwen, L Emmett, B Ho
BJU Int. 2017;119:209–215 • 2017
View 1 Excerpt

The Clinical Impact of Additional Late PET/CT Imaging with 68Ga-PSMA-11 (HBED-CC) in the Diagnosis of Prostate Cancer.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine • 2017
View 1 Excerpt

cancer recurrences after surgery : individualized medicine or new standard in salvage treatment

PJ Roach, R Francis, L Emmett
2017

68Ga-PSMA ligand PET/CT in patients with prostate cancer: How we review and report

Cancer imaging : the official publication of the International Cancer Imaging Society • 2016

Similar Papers

Loading similar papers…